Maryland Matters
March 19, 2024
Josh Kurtz
Excerpt:
“The General Assembly will wait until 2025 to consider this legislation, which gives the Board time to finalize action on upper payment limits for drugs purchased by state and local governments,” said Sen. Dawn Gile (D-Anne Arundel), sponsor of the Senate bill, said in a written statement.
“There is widespread agreement in the General Assembly that we need to help bring down the costs of expensive prescription drugs. Waiting until next year is the right decision and gives the Board time to fulfill its existing mandate,” she said.
Vincent DeMarco, president of Maryland Health Care for All, says that the organization looks forward to working with the legislature next year on the issue.
“Although we are disappointed that the General Assembly did not expand the Board’s authority this year, after the Board makes high cost drugs more affordable for state and local governments in the next few months, we will work hard to ensure that the Maryland General Assembly will in 2025 expand the Board’s authority to allow it to make high cost drugs more affordable for all Marylanders,” he said.
Read the full article at MarylandMatters.org
Last modified: March 22, 2024
